ConductScience.org, home

Gene · 7732

RNF112: ring finger protein 112

12 sourcesgene-search-2026-11-11-0.2.0

Download JSON
Cite this record

ConductScience Library. RNF112: ring finger protein 112. Genes, record 7732. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/7732

On this page

Gene

Symbol
RNF112
HGNC
Name
ring finger protein 112
HGNC
NCBI Gene ID
7732
NCBI Gene
HGNC ID
HGNC:12968
HGNC
Ensembl
ENSG00000128482
NCBI Gene
Aliases
BFP, ZNF179
NCBI Gene
Type
protein-coding
NCBI Gene

Proteins1

Reviewed human proteins whose Swiss-Prot entry states the gene.

UniProt entryProteinLengthStructuresGene stated in
Q9ULX5RING finger protein 1126310Ensembl, GeneID, HGNC

Source UniProt

Patents16

Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.

PublicationPublishedSEQ ID NOProteinSource
JP 2026004568 A2026-01-1462232Q9ULX5Espacenet
EP 4641201 A22025-10-2921064Q9ULX5Espacenet
JP 2025529142 A2025-09-043727Q9ULX5Espacenet
US 12371689 B22025-07-293727Q9ULX5Espacenet
JP 2025517969 A2025-06-1221064Q9ULX5Espacenet
JP 2025032204 A2025-03-1134899Q9ULX5Espacenet
EP 4461818 A22024-11-1334899Q9ULX5Espacenet
JP 2023058610 A2023-04-2534899Q9ULX5Espacenet
US 11446398 B22022-09-2074713Q9ULX5Espacenet
US 11400116 B22022-08-023634Q9ULX5Espacenet

1 to 10 of 16

See all 16 patents

Drugs0

Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.

None in this release.

Trials0

Trials of those drugs. A trial joins the gene only through a drug that acts on it.

None in this release.

NIH grants2,355

NIH grants whose papers are about the gene, through NIH's grant-paper links.

GrantTitleRNF112 papersNewest fiscal year
P30CA008748Cancer Center Support Grant222025
RM1HG009490Center for Genomic Editing and Recording: Development and Application of Next-Generation Genome and Epigenome Editing Methods to Advance the Study and Treatment of Human Disease172025
P30CA060553The Robert H. Lurie Comprehensive Cancer Center122025
T32HG000044Institutional Training Grant in Genome Science92025
P30CA014051Cancer Center Support (Core) Grant72025
P01CA092584Structural Cell Biology of DNA Repair Machines62025
P30CA013696Cancer Center Support Grant62025
P30CA082103Cancer Center Support Grant62025
P30CA124435Stanford Cancer Institute62025
R01AG011085Ubiquitin‐mediated proteolysis and cell cycle control62025

1 to 10 of 2,355Source NIH's project files

See all 2,355 nih grants

Papers1,998

Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.

TitleJournalYearPMIDFound bySource
Pathogenic KIF1A variants differentially disrupt axonal trafficking and impede synaptic development.J Cell Biol202642704317PubTator, text miningPubMed
A simple and versatile fluorescence-based method to enhance prime editing in human pluripotent stem cells.BMC Methods202642453142PubTator, text miningPubMed
Characterization of a transmembrane-activating STING agonist using genetically humanized mice.Cell Rep202642228573PubTator, text miningPubMed
Modeling stimulus-induced stress responses in microglia-like cells using a commercial iPSC-dCas9-KRAB line.Stem Cell Res202642214129PubTator, text miningPubMed
RNF112 mediates immunosuppression to inhibit the proliferation of cervical cancer by Foxm1.Transl Cancer Res202642180965PubTator, text miningPubMed
CBX2 phase-separation contributes to homologous recombination repair and drug resistance in ovarian cancer.Cell Death Dis202641888115PubTator, text miningPubMed
Lysosomal down-regulation of the mu opioid receptor is opposed by the Retromer complex.Sci Adv202641861010PubTator, text miningPubMed
Membrane-associated Rhes-Slc4a7 complex orchestrates tunneling nanotube formation and mutant Huntingtin spread.Sci Adv202641861004PubTator, text miningPubMed
Synthetic lethality between RB-loss and E2F3 inhibition in small cell cancers targeted by pyrimidine synthesis blockade.Proc Natl Acad Sci U S A202641860961PubTator, text miningPubMed
Ex vivo and in vivo CRISPR/Cas9 screenings identify the roles of protein N-glycosylation in regulating T-cell activation and functions.Elife202641860948PubTator, text miningPubMed

1 to 10 of 1,998

See all 1,998 papers

Sources 12

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
  • GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
  • HGNCCC0
  • NCBI GenePublic domain (US government)
  • NIH's project files and grant-paper linksPublic domain
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
  • GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
  • HGNCCC0: https://www.genenames.org/about/license/
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this gene from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/genes/v1/7732

GET https://conductscience.org/api/genes/v1/7732/patents